| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:464.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Rush University Hypertension Service, Rush-Presbyterian St. Lukes Medical Center, Chicago, Ill.
Correspondence to Henry R. Black, MD, Department of Preventive Medicine, Rush-Presbyterian St. Lukes Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL 60612. E-mail hblack{at}rush.edu
Several clinical trials using a blood pressure (BP) treatment algorithm focused on a predetermined goal have achieved better control rates than those of national survey data. These trials reached the Sixth Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) diastolic blood pressure (DBP) goal of <90 mm Hg in >90% of volunteers and systolic blood pressure (SBP) goal of <140 mm Hg in >60% of volunteers. We evaluated BP control of 437 consecutive patients after at least one year of follow up in a specialist clinic which employed "goal-oriented management," ie, treating to a specific BP goal without a formal drug treatment algorithm, to determine whether JNC VI goals could be achieved. Overall, 276 (63%) patients achieved SBP goal, with 376 (86%) at DBP goal and 358 (59%) at both goals. Only 23% of patients were on monotherapy, with 34% requiring 2 drugs and 37% requiring 3 or more medications. There was no substantial difference in BP control rates among age, gender, and ethnicity subgroups. However, in the 20% of patients who were diabetic, only 52% had a BP of <140 mm Hg and <90 mm Hg, whereas fewer (22% and 15%, respectively) achieved the more stringent goals of JNC VI and the American Diabetic Association (ADA)/National Kidney Foundation (NKF). Goal-oriented management achieved dramatically better control rates than what is reported. Although DBP control was easy to achieve, achieving SBP goal still remained difficult. Employing goal-oriented management can translate BP control results achieved in clinical trials into outpatient practice.
Key Words: hypertension, detection and control blood pressure monitoring antihypertensive therapy antihypertensive agents
This article has been cited by other articles:
![]() |
P. A. Sarafidis and G. L. Bakris Resistant Hypertension An Overview of Evaluation and Treatment. J. Am. Coll. Cardiol., November 25, 2008; 52(22): 1749 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moser and J. F. Setaro Clinical practice. Resistant or difficult-to-control hypertension. N. Engl. J. Med., July 27, 2006; 355(4): 385 - 392. [Full Text] [PDF] |
||||
![]() |
T. J. Wang and R. S. Vasan Epidemiology of Uncontrolled Hypertension in the United States Circulation, September 13, 2005; 112(11): 1651 - 1662. [Full Text] [PDF] |
||||
![]() |
J. R. Banegas, J. Segura, L. M. Ruilope, M. Luque, R. Garcia-Robles, C. Campo, F. Rodriguez-Artalejo, J. Tamargo, and on behalf of the CLUE Study Group Investigators Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in Spain Hypertension, June 1, 2004; 43(6): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Singer, M. Izhar, and H. R. Black Guidelines for Hypertension: Are Quality-Assurance Measures on Target? Hypertension, February 1, 2004; 43(2): 198 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
Goal-Oriented Hypertension Management Journal Watch Cardiology, November 22, 2002; 2002(1122): 3 - 3. [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |